Literature DB >> 26841640

Insulin-Like Growth Factor Binding Proteins--an Update.

Leon A Bach.   

Abstract

The insulin-like growth factor (IGF) system is essential for normal growth and development, and its perturbation is implicated in a number of diseases. IGF activity is finely regulated by a family of six high-affinity IGF binding proteins (IGFBPs). 1GFBPs usually inhibit IGF actions but may enhance them under certain conditions. Additionally, IGFBPs bind non-IGF ligands in the extracellular space, cell membrane, cytoplasm and nucleus, thereby modulating cell proliferation, survival and migration in an IGF-independent manner. IGFBP activity is regulated by transcriptional mechanisms as well as by post-translational modifications and proteolysis. Understanding the balance between the various actions of IGFBPs in vivo may lead to novel insights into disease processes and possible IGFBP-based therapeutics.

Mesh:

Substances:

Year:  2015        PMID: 26841640

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  15 in total

1.  Airway smooth muscle cells are insensitive to the anti-proliferative effects of corticosteroids: The novel role of insulin growth factor binding Protein-1 in asthma.

Authors:  Hong Bui; Yassine Amrani; Brian Deeney; Reynold A Panettieri; Omar Tliba
Journal:  Immunobiology       Date:  2019-05-23       Impact factor: 3.144

Review 2.  Placental phenotype and the insulin-like growth factors: resource allocation to fetal growth.

Authors:  Amanda N Sferruzzi-Perri; Ionel Sandovici; Miguel Constancia; Abigail L Fowden
Journal:  J Physiol       Date:  2017-05-23       Impact factor: 5.182

3.  TXNDC5 contributes to rheumatoid arthritis by down-regulating IGFBP1 expression.

Authors:  J Li; B Xu; C Wu; X Yan; L Zhang; X Chang
Journal:  Clin Exp Immunol       Date:  2017-12-21       Impact factor: 4.330

4.  Function of insulin-like growth factor 1 receptor in cancer resistance to chemotherapy.

Authors:  Jingsheng Yuan; Zhijie Yin; Kaixiong Tao; Guobing Wang; Jinbo Gao
Journal:  Oncol Lett       Date:  2017-10-26       Impact factor: 2.967

5.  Large-scale analysis of variation in the insulin-like growth factor family in humans reveals rare disease links and common polymorphisms.

Authors:  Peter Rotwein
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

6.  Components of IGF-axis in growth disorders: a systematic review and patent landscape report.

Authors:  Amit Singh; Ketan Pajni; Inusha Panigrahi; Navdeep Dhoat; Sabyasachi Senapati; Preeti Khetarpal
Journal:  Endocrine       Date:  2022-05-06       Impact factor: 3.925

Review 7.  Current Insights into the Role of the Growth Hormone-Insulin-Like Growth Factor System in Short Children Born Small for Gestational Age.

Authors:  Judith S Renes; Jaap van Doorn; Anita C S Hokken-Koelega
Journal:  Horm Res Paediatr       Date:  2019-09-11       Impact factor: 2.852

8.  Insulin-like growth factor 1 rescues R28 retinal neurons from apoptotic death through ERK-mediated BimEL phosphorylation independent of Akt.

Authors:  Dejuan Kong; Lijie Gong; Edith Arnold; Sumathi Shanmugam; Patrice E Fort; Thomas W Gardner; Steven F Abcouwer
Journal:  Exp Eye Res       Date:  2016-08-07       Impact factor: 3.467

9.  Reduction of venous pressure during the resection of liver metastases compromises enteric blood flow: IGFBP-1 as a novel biomarker of intestinal barrier injury.

Authors:  Hermes Vieira Barbeiro; Marcel Autran César Machado; Heraldo Possolo de Souza; Fabiano Pinheiro da Silva; Marcel Cerqueira César Machado
Journal:  Clinics (Sao Paulo)       Date:  2017-10       Impact factor: 2.365

10.  Structures of insect Imp-L2 suggest an alternative strategy for regulating the bioavailability of insulin-like hormones.

Authors:  Nikolaj Kulahin Roed; Cristina M Viola; Ole Kristensen; Gerd Schluckebier; Mathias Norrman; Waseem Sajid; John D Wade; Asser Sloth Andersen; Claus Kristensen; Timothy R Ganderton; Johan P Turkenburg; Pierre De Meyts; Andrzej M Brzozowski
Journal:  Nat Commun       Date:  2018-09-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.